Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E24.23 EPS (ttm)1.81 Insider Own0.10% Shs Outstand5.64B Perf Week1.60%
Market Cap246.59B Forward P/E14.29 EPS next Y3.06 Insider Trans-13.98% Shs Float5.56B Perf Month4.31%
Income10.67B PEG5.00 EPS next Q0.75 Inst Own74.90% Short Float1.25% Perf Quarter3.16%
Sales53.86B P/S4.58 EPS this Y-11.90% Inst Trans-2.17% Short Ratio3.17 Perf Half Y4.36%
Book/sh10.43 P/B4.20 EPS next Y5.29% ROA7.10% Target Price45.57 Perf Year19.86%
Cash/sh2.06 P/C21.22 EPS next 5Y4.85% ROE17.40% 52W Range36.00 - 46.47 Perf YTD0.25%
Dividend1.44 P/FCF45.38 EPS past 5Y1.00% ROI10.20% 52W High-5.98% Beta0.64
Dividend %3.29% Quick Ratio1.30 Sales past 5Y0.80% Gross Margin79.60% 52W Low21.36% ATR0.57
Employees92400 Current Ratio1.50 Sales Q/Q1.60% Oper. Margin23.30% RSI (14)70.23 Volatility1.27% 1.32%
OptionableYes Debt/Eq0.77 EPS Q/Q14.90% Profit Margin21.30% Rel Volume0.57 Prev Close43.76
ShortableYes LT Debt/Eq0.61 EarningsJul 30 BMO Payout69.60% Avg Volume21.89M Price43.69
Recom2.40 SMA202.11% SMA505.02% SMA2002.44% Volume625,611 Change-0.16%
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Jun-26-19 06:07AM  Conatus' Emricasan Lags Primary Goal in Liver Function Study Zacks
Jun-25-19 08:07PM  3 Dividend Stocks That Could Pay You the Rest of Your Life Motley Fool
05:45PM  Pfizer (PFE) Flat As Market Sinks: What You Should Know Zacks
11:03AM  Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015
10:32AM  Abbvie Decides to Acquire Allergan Zacks
10:14AM  AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20 Zacks
Jun-24-19 04:23PM  Why These Innovative Biotech ETFs Soaring Zacks
04:14PM  This Biotech Stock Is Facing A 'Whale' As Pfizer Unveils Gene Therapy Data Investor's Business Daily
11:45AM  Eldorado to Buy Caesars Zacks
11:04AM  BioMarin Gets $15M From Pfizer on Talzenna's European Nod Zacks
10:06AM  U.S. Senate Takes on Big Tech, Plus "Merger Monday" Zacks
08:33AM  Pfizer's Talzenna Gets Approval in Europe for Breast Cancer Zacks
Jun-23-19 09:00AM  These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now? Motley Fool
08:09AM  Is There An Opportunity With Pfizer Inc.'s (NYSE:PFE) 50% Undervaluation? Simply Wall St.
08:06AM  Do Institutions Own Shares In Pfizer Inc. (NYSE:PFE)? Simply Wall St.
Jun-22-19 03:07PM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs Benzinga
Jun-21-19 10:50PM  PFIZER INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Pfizer Inc. - PFE Business Wire
05:37PM  Amags plan to bypass female libido drug pitfalls? Social media. American City Business Journals
04:33PM  Dow Jones Today: A Typical Summer Friday InvestorPlace
11:57AM  Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA Benzinga
10:45AM  European Commission Approves TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer Business Wire
09:40AM  Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma Zacks
09:20AM  Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up Zacks
09:07AM  Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod Zacks
Jun-20-19 10:38AM  Is Pfizer Overpaying for Array Biopharma? Motley Fool
09:44AM  Stock Market News For Jun 20, 2019 Zacks
04:18AM  GSK offers concessions to address EU concerns over Pfizer deal Reuters
03:56AM  GSK offers concessions to address EU concerns over Pfizer deal Reuters
Jun-19-19 04:49PM  Here's Pfizer's Motivation Behind Its Biggest Takeover In 3 Years Investor's Business Daily
01:37PM  GSK kicks off sale of $1.2 billion consumer health drugs: sources Reuters
11:34AM  Pfizer Stock Is The Biggest Pharma But Should You Buy It? Investor's Business Daily
11:20AM  Cancer/Gene Therapy Biotechs in Focus After Pfizer-Array Deal Zacks
10:02AM  2 Midcaps to Watch Should Pfizer-Array Deal Spark M&A Fever in Biotech Land
09:27AM  A Beloved Biotech ETF Could Lure Traders Again Benzinga
09:06AM  Big Drugmakers That May Tread the M&A Path After Pfizer Zacks
07:56AM  3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company InvestorPlace
Jun-18-19 05:57PM  SHAREHOLDER ALERT: WeissLaw LLP Investigates Array BioPharma Acquisition PR Newswire
05:45PM  Pfizer (PFE) Gains But Lags Market: What You Should Know Zacks
03:51PM  Papa Johns Auditor Swap Is Not a Good Look Motley Fool
10:27AM  Protalix (PLX) Completes Enrollment in Fabry Disease Study Zacks
10:00AM  Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts Business Wire
09:55AM  Pfizer-Array Biopharma Deal Bump Up Biotech ETFs Zacks
09:51AM  Cancer Therapy Stocks Soar After Pfizer Deal Investopedia
09:51AM  Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio Zacks
09:35AM  Company News For Jun 18, 2019 Zacks
08:00AM  3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal Motley Fool
07:09AM  Shares of cancer-therapy companies skyrocket after Pfizer acquisition news MarketWatch
02:07AM  PRESS DIGEST - Wall Street Journal - June 18 Reuters
Jun-17-19 05:06PM  What Happened in the Stock Market Today Motley Fool
05:00PM  Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon Motley Fool
04:48PM  How Pfizer's $11.4 Billion Takeover Of Array Signals More Mergers Investor's Business Daily
04:41PM  Dow Jones Today: Almost a Case of the Mondays InvestorPlace
04:26PM  Stocks End Slightly Higher in Cautious Trading Ahead of Federal Reserve Meeting
04:23PM  Pfizer acquires Array in 2nd major Boulder bioscience merger this month American City Business Journals
04:19PM  US STOCKS-Faith in the Fed nudges Wall Street higher Reuters
04:17PM  Stocks close higher as social media, real estate shares lead MarketWatch
04:05PM  5 Top Stock Trades for Tuesday: FB, NFLX, GILD, TSLA InvestorPlace
03:48PM  Stocks To Buy: Is It Time To Buy Or Sell These Large-Cap Stocks? Investor's Business Daily
03:23PM  Pfizer Is Buying Array BioPharma, Seeking to Broaden Lineup of Cancer Drugs
03:20PM  Pfizer Is the Latest Drug Company to Put Its Credit Rating at Risk With M&A
02:58PM  The 5 Worst Dow Jones Stocks So Far in 2019 InvestorPlace
02:50PM  US STOCKS-Faith in the Fed pushes Wall Street higher Reuters
01:20PM  US STOCKS-Wall Street holds on to gains; Fed policy meeting eyed Reuters
12:40PM  Pfizer Inc. -- Moody's: Pfizer's acquisition of Array is credit negative Moody's
12:10PM  US STOCKS-Wall Street moves higher; Fed policy meeting eyed Reuters
11:59AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Array BioPharma Inc. to Pfizer Inc. is Fair to Shareholders GlobeNewswire
11:43AM  Pfizer Nabs Array Biopharma in $11.4 Billion Takeover of Cancer Drug Specialist
10:46AM  Big Ticket Mergers Are in Focus Zacks
10:43AM  ARRAY BIOPHARMA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout GlobeNewswire
10:33AM  "Merger Monday" Returns: Pfizer Buying Array, T-Mobile-Sprint on Ice? Zacks
10:29AM  US STOCKS-Wall Street moves higher; Fed policy meeting on the horizon Reuters
09:35AM  Stocks mixed as Fed meeting comes into view MarketWatch
09:26AM  Pfizer buys cancer treatment innovator Array BioPharma for $11 billion American City Business Journals
09:06AM  US STOCKS-Wall St set for muted open; Fed meet in focus Reuters
08:43AM  S&P places Pfizer ratings on CreditWatch negative after $11.4 billion Array deal MarketWatch
07:27AM  Pfizer bolsters cancer portfolio with $10.64 billion deal for Array Reuters
06:56AM  Pfizer to buy Array for $10.64 billion Reuters
06:56AM  Array BioPharma's stock rockets after $11.4 billion buyout deal with Pfizer MarketWatch
06:54AM  Pfizer to buy Array for $10.64 bln Reuters
06:54AM  Pfizer to Acquire Array BioPharma PR Newswire
04:21AM  Stocks - Pfizer, Target Fall Premarket; Deutsche Bank, Boeing Rise
Jun-14-19 10:07AM  Merck Plans Its First Investor Day in 5 Years. Heres What to Watch.
09:12AM  Dow 30 Stock Roundup: United Technologies-Raytheon Merger, Merck's Tilos Buyout Zacks
08:34AM  Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti Zacks
Jun-13-19 01:43PM  J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns definitive ratings to six CMBS classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB Moody's
08:24AM  Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study Zacks
Jun-12-19 06:38PM  Galapagos Ends Enrollment in Osteoarthritis Study Before Time Zacks
06:21PM  Novartis Reports Data on Cosentyx for Psoriatic Arthritis Zacks
05:45PM  Pfizer (PFE) Gains As Market Dips: What You Should Know Zacks
10:36AM  Top Ranked Income Stocks to Buy for June 12th Zacks
08:33AM  Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer Zacks
08:28AM  Boost Your Portfolio's Health With These 3 Big Drug Stocks Zacks
08:00AM  Pfizer Announces Results from XELJANZ® XR (tofacitinib) ORAL Shift Study, The First Phase 3b/4 Study to Evaluate Methotrexate Withdrawal with a JAK Inhibitor Business Wire
Jun-10-19 01:35PM  INMB: TNF- Inhibition Associated with Decreased Risk of Developing Alzheimers Disease Zacks Small Cap Research
10:59AM  9 Hot Stocks to Buy Now InvestorPlace
09:39AM  TherapeuticsMD Enters Agreement to Market Drugs Outside US Zacks
07:23AM  Jim Cramer Weighs In On Tesla, PayPal And More Benzinga
Jun-07-19 10:50PM  PFIZER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Pfizer Inc. - PFE PR Newswire
07:45AM  Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far Motley Fool
04:01AM  Germany's Stada buys six of GSK's consumer brands, eyes further deals Reuters
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Merck & Co., Inc. and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MACKENZIE ALEXANDER RExecutive Vice PresidentJun 20Sale44.0030,0001,320,00080,094Jun 21 04:08 PM
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 01Sale42.755,000213,75040,057Feb 01 07:21 PM
Dolsten MikaelPresident R&DJan 31Option Exercise29.78125,9683,751,425362,051Feb 01 07:28 PM
LANKLER DOUGLAS MExecutive Vice PresidentJan 30Sale41.1938,8001,598,07145,057Feb 01 07:21 PM
READ IAN CChairman & CEONov 02Option Exercise26.641,100,20129,312,5881,760,958Nov 06 03:46 PM
PFIZER INC10% OwnerOct 15Buy18.0055,5561,000,00822,032,040Oct 17 05:17 PM
Dolsten MikaelPresident R&DSep 13Option Exercise24.56181,7124,462,167234,299Sep 17 04:08 PM
OLSON LAURIE JExecutive Vice PresidentAug 13Sale41.0010,214418,77472,672Aug 14 05:04 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 03Sale39.5125,6421,013,171102,412Aug 06 03:19 PM
GOETTLER MICHAELGroup PresidentAug 01Sale39.7019,198762,11611,924Aug 03 03:38 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerAug 01Sale40.1626,8141,076,93383,846Aug 03 03:36 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentAug 01Sale40.0420,942838,5724,643Aug 03 03:35 PM
DAMELIO FRANK AExecutive Vice PresidentAug 01Sale40.00150,4846,019,360337,391Aug 03 03:33 PM
SUSMAN SALLYExecutive Vice PresidentJul 20Sale37.2240,3811,502,925115,096Jul 24 01:09 PM
READ IAN CChairman & CEOJul 16Sale37.36486,75318,186,315659,440Jul 17 04:59 PM